Results 231 to 240 of about 332,472 (376)

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

open access: yesFrontiers in Pharmacology
Eleonora Lai   +7 more
doaj   +1 more source

Symptom burden in end-stage liver disease: a prospective cohort study of the symptoms experienced by patients and the role of palliative care. [PDF]

open access: yesTherap Adv Gastroenterol
Oliveira HM   +8 more
europepmc   +1 more source

Immediate Reconstruction of Pancretaticogastrostomy Following Hepatopancreatoduodenectomy for Biliary Tact Cancer: A Single‐Center Review of 33 Consecutive Patients

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study showed that the pancreaticogastrostomy technique in HPD of biliary tract cancer reduced the incidence of pancreatic fistula from 45% to 12%. In‐hospital mortality was also reduced from 27% to 3%. ABSTRACT Background and Purpose Although hepatopancreaticoduodenectomy (HPD) is effective for margin‐negative curative resection of biliary tract ...
Ryusei Matsuyama   +9 more
wiley   +1 more source

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L. [PDF]

open access: yesDiagnostics (Basel)
Kawanaka M   +37 more
europepmc   +1 more source

Personalized Kirigami Strain Sensors for in vivo Applications

open access: yesAdvanced Intelligent Systems, EarlyView.
Rapid prototyping of strain sensors is demonstrated using a laser cutter that both converts carbon‐based material to strain responsible graphene and generates cuts in a kirigami‐style pattern that allows enhanced substrate flexibility. This method is used to generate wearable sensors for monitoring heart rate, limb/finger motion, and abdominal ...
Siheng Sean You   +7 more
wiley   +1 more source

Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice

open access: yesJournal of Lipid Research
Metabolic dysfunction-associated steatotic liver disease is the most common form of liver disease and poses significant health risks to patients who progress to metabolic dysfunction-associated steatohepatitis.
Tomasz K. Bednarski   +6 more
doaj  

Early Enzyme Replacement Therapy Does Not Prevent the Protein Losing Enteropathy Syndrome in Neurovisceral Gaucher Disease

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Gaucher disease (GD) is a rare lysosomal storage disorder characterized by multisystemic involvement. With the advent of enzyme replacement therapy (ERT), patient survival has improved, revealing new long‐term complications. We report a case of a 4‐year‐old male with severe neurovisceral GD who developed protein‐losing enteropathy (PLE ...
Vincenza Gragnaniello   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy